Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.60 |
| ▸ | DPP4 | P27487 | 2/20 | 0.60 |
| ▸ | FAP | Q12884 | 2/20 | 0.60 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.60 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.60 |
| ▸ | AKT1 | P31749 | 1/20 | 0.54 |
| ▸ | AKT2 | P31751 | 1/20 | 0.54 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.54 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.50 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HRH2 | P25021 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6162776 | 1.00 | DPP7 (0.60) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL31278998 | 0.93 | DPP7 (0.57) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL7440658 | 0.88 | DPP4 (0.57) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL14311579 | 0.87 | DPP7 (0.61) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL8881323 | 0.85 | DPP4 (0.55) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL7364169 | 0.85 | DPP4 (0.55) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL6160377 | 0.85 | AKT1 (0.60) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL6166321 | 0.85 | AKT1 (0.60) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL7369343 | 0.84 | DPP4 (0.54) | DPP7DPP4FAPDPP8DPP9 | |
| SCHEMBL8879407 | 0.83 | DPP4 (0.53) | DPP7DPP4FAPDPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1134213-B1 | Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides | PFIZER (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-0832065-B1 | SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS | PFIZER (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1134213-A2 | Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides | PFIZER INC. (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6277877-B1 | GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS | PFIZER, INC. | 2001-08-21 | — | — | US | disclosed |
| US-6107329-A | HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS | PFIZER, INC. (US) | 2000-08-22 | — | — | US | disclosed |
| EP-0832065-A1 | SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS | PFIZER INC. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996039384-A1 | SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS | PFIZER, INC. (US) | 1996-12-12 | — | — | WO | disclosed |